In order to find out how semaglutide compares to placebo in terms of weight loss, safety, and tolerability in individuals who are overweight or obese, the Semaglutide Treatment Effect in People with Obesity (STEP) program has been established
In clinical practice, SGLT2 inhibitors are often initiated first due to their oral administration and broader reimbursement, with GLP-1 receptor agonists subsequently added to address persistent hyperglycemia, excess body weight, or residual albuminuria [84,85]
Christopher Sparrow, MD, is an Advanced heart failure cardiologist with OSF HealthCare
Dual Pathway Growth Hormone Signaling Although both peptides promote endogenous growth hormone release, they do so through separate biological mechanisms
Very high-fibre foods may aggravate early gastrointestinal symptoms, so increasing fibre intake gradually is recommended
Ive been on it since October/2025